CD80 variant immunomodulatory proteins and uses thereof
US11117948B2 · kind B2 · utility
11Cited by
77References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 28, 2021 |
| Grant date | Sep 14, 2021 |
| Priority date | — |
| Expiry date | Jan 28, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.